Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma

This study is currently recruiting participants. (see Contacts and Locations)

Verified January 2016 by Verastem, Inc.

Sponsor:

Information provided by (Responsible Party):

Verastem, Inc.

ClinicalTrials.gov Identifier:

NCT01991938

First received: November 18, 2013

Last updated: January 8, 2016

Last verified: January 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2016 (Final data collection date for primary outcome measure)